Böni R - Search Results

1

Non-invasive assessment of tumour cell proliferation with positron emission tomography and [76Br]bromodeoxyuridine.

Böni R, Bläuenstein P, Dummer R, von Schulthess GK, Schubiger PA, Steinert HC. Böni R, et al. Melanoma Res. 1999 Dec;9(6):569-73. doi: 10.1097/00008390-199912000-00005. Melanoma Res. 1999. PMID: 10661767

2

Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose.

Böni R, Böni RA, Steinert H, Burg G, Buck A, Marincek B, Berthold T, Dummer R, Voellmy D, Ballmer B, et al. Böni R, et al. Among authors: boni ra. Br J Dermatol. 1995 Apr;132(4):556-62. doi: 10.1111/j.1365-2133.1995.tb08711.x. Br J Dermatol. 1995. PMID: 7748746

3

Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.

Steinert HC, Huch Böni RA, Buck A, Böni R, Berthold T, Marincek B, Burg G, von Schulthess GK. Steinert HC, et al. Among authors: boni r. Radiology. 1995 Jun;195(3):705-9. doi: 10.1148/radiology.195.3.7753998. Radiology. 1995. PMID: 7753998

4

Early detection of melanoma metastasis using fludeoxyglucose F 18 positron emission tomography.

Böni R, Huch-Böni RA, Steinert H, von Schulthess GK, Burg G. Böni R, et al. Arch Dermatol. 1996 Aug;132(8):875-6. doi: 10.1001/archderm.1996.03890320023003. Arch Dermatol. 1996. PMID: 8712836 No abstract available.

5

Lack of expression of dopamine D2 receptors in malignant melanoma: evidence for interaction of iodobenzofurans with melanin.

Böni R, Steinert H, Böni RA, Lichtensteiger W, Dummer R, Hartman DS, von Schulthess GK, Burg G, Westera G. Böni R, et al. Among authors: boni ra. Dermatology. 1996;193(3):198-202. doi: 10.1159/000246245. Dermatology. 1996. PMID: 8944340

6

D1 dopamine receptors are not expressed in human melanoma.

Böni R, Lichtensteiger W, Steinert HC, Böni RA, Früh H, Dummer R, Hartmann DG, Laine E, Burg G. Böni R, et al. Among authors: boni ra. Melanoma Res. 1997 Apr;7(2):117-9. doi: 10.1097/00008390-199704000-00005. Melanoma Res. 1997. PMID: 9167177

7

Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and results in patients.

Böni R, Steinert H, Huch Böni R, Von Schulthess GK, Meyer J, Dummer R, Burg G, Westera G. Böni R, et al. Br J Dermatol. 1997 Jul;137(1):96-100. Br J Dermatol. 1997. PMID: 9274632

8

Anti-melanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanoma.

Böni R, Huch Böni RA, Steinert H, Dummer R, Burg G, von Schulthess GK. Böni R, et al. Dermatology. 1995;191(2):119-23. doi: 10.1159/000246528. Dermatology. 1995. PMID: 8520057 Clinical Trial.

9

MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma.

Böni R, Doguoglu A, Burg G, Müller B, Dummer R. Böni R, et al. J Am Acad Dermatol. 1996 Sep;35(3 Pt 1):416-8. doi: 10.1016/s0190-9622(96)90607-6. J Am Acad Dermatol. 1996. PMID: 8784279

10

[123I-alpha-methyltyrosine scintigraphy in malignant melanoma].

Steinert H, Böni R, Huch-Böni RA, Capaul R, von Schulthess GK, Westera G. Steinert H, et al. Among authors: boni r. Nuklearmedizin. 1997 Mar;36(2):36-41. Nuklearmedizin. 1997. PMID: 9148271 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

405 results

Search Page

Filters